Literature DB >> 1951547

When do cardiovascular parameters return to their preconception values?

E L Capeless1, J F Clapp.   

Abstract

To determine if the postpartum period is reflective of a woman's cardiovascular status before pregnancy, we performed serial studies of 13 women before conception and at 6 and 12 weeks post partum. All pregnancies were singleton without hypertensive complications. Cardiac output, stroke volume, and end-diastolic volume were calculated with M-mode echocardiography from the left ventricular dimensions with subjects in the left lateral position. Systemic vascular resistance was calculated from cardiac output and simultaneous measurements of blood pressure. Stroke volume and end-diastolic volume remained consistently elevated over preconception values at 6 and 12 weeks. Systemic vascular resistance remained decreased, compared with baseline, at 12 weeks. Thus cardiovascular parameters had not returned to the preconception baseline, and previous studies that have used this time period for comparison have underestimated the contribution of stroke volume to the total change in cardiac output during pregnancy.

Entities:  

Mesh:

Year:  1991        PMID: 1951547     DOI: 10.1016/0002-9378(91)90432-q

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  13 in total

1.  Cardiac disease in pregnancy: value of echocardiography.

Authors:  Sarah Tsiaras; Athena Poppas
Journal:  Curr Cardiol Rep       Date:  2010-05       Impact factor: 2.931

2.  Cardiac hemodynamics before, during and after elective cesarean section under spinal anesthesia in low-risk women.

Authors:  M Ram; A Lavie; S Lev; Y Blecher; U Amikam; Y Shulman; T Avnon; E Weiner; A Many
Journal:  J Perinatol       Date:  2017-04-13       Impact factor: 2.521

3.  B-type natriuretic peptide and echocardiography reflect volume changes during pregnancy.

Authors:  Janet M Burlingame; Kelly Yamasato; Hyeong Jun Ahn; Todd Seto; W H Wilson Tang
Journal:  J Perinat Med       Date:  2017-07-26       Impact factor: 1.901

Review 4.  Management of pregnancy in patients with congenital heart disease.

Authors:  Ian S Harris
Journal:  Prog Cardiovasc Dis       Date:  2011 Jan-Feb       Impact factor: 8.194

5.  The critically ill obstetric patient - Recent concepts.

Authors:  Anjan Trikha; Pm Singh
Journal:  Indian J Anaesth       Date:  2010-09

Review 6.  Preconception Counseling for Women with Congenital Heart Disease.

Authors:  Chun-Wei Lu; Mei-Hwan Wu; Jou-Kou Wang; Min-Tai Lin; Chun-An Chen; Shenn-Nan Chiu; Hsin-Hui Chiu
Journal:  Acta Cardiol Sin       Date:  2015-11       Impact factor: 2.672

Review 7.  [Management of heart diseases in pregnancy: rheumatic and congenital heart disease, myocardial infarction and post partum cardiomyopathy].

Authors:  M Westhoff-Bleck; D Hilfiker-Kleiner; H H Günter; E Schieffer; H Drexler
Journal:  Internist (Berl)       Date:  2008-07       Impact factor: 0.743

8.  Augmented uterine artery blood flow and oxygen delivery protect Andeans from altitude-associated reductions in fetal growth.

Authors:  Colleen Glyde Julian; Megan J Wilson; Miriam Lopez; Henry Yamashiro; Wilma Tellez; Armando Rodriguez; Abigail W Bigham; Mark D Shriver; Carmelo Rodriguez; Enrique Vargas; Lorna G Moore
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-02-25       Impact factor: 3.619

9.  Inhibition of peroxisome proliferator-activated receptor γ: a potential link between chronic maternal hypoxia and impaired fetal growth.

Authors:  Colleen G Julian; Ivana V Yang; Vaughn A Browne; Enrique Vargas; Carmelo Rodriguez; Brent S Pedersen; Lorna G Moore; David A Schwartz
Journal:  FASEB J       Date:  2013-12-04       Impact factor: 5.191

10.  Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute.

Authors:  Anna R Hemnes; David G Kiely; Barbara A Cockrill; Zeenat Safdar; Victoria J Wilson; Manal Al Hazmi; Ioana R Preston; Mandy R MacLean; Tim Lahm
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.